Cereno Scientific AB (OSTO:CRNO B) Other Current Liabilities : kr18.54 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Other Current Liabilities?

Cereno Scientific AB's other current liabilities for the quarter that ended in Mar. 2025 was kr18.54 Mil.

Cereno Scientific AB's quarterly other current liabilities declined from Sep. 2024 (kr17.59 Mil) to Dec. 2024 (kr17.50 Mil) but then increased from Dec. 2024 (kr17.50 Mil) to Mar. 2025 (kr18.54 Mil).

Cereno Scientific AB's annual other current liabilities increased from Dec. 2022 (kr4.12 Mil) to Dec. 2023 (kr16.23 Mil) and increased from Dec. 2023 (kr16.23 Mil) to Dec. 2024 (kr17.50 Mil).

Cereno Scientific AB Other Current Liabilities Historical Data

The historical data trend for Cereno Scientific AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Other Current Liabilities Chart

Cereno Scientific AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

1.87

2.56

4.12

16.23

17.50

Cereno Scientific AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															4.73	7.54	17.59	17.50	18.54

Cereno Scientific AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Cereno Scientific AB Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cereno Scientific AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

4A1:Germany

Address

BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.cerenoscientific.se

Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines